Cell-Sized Lipid Vesicles as Artificial Antigen-Presenting Cells for Antigen-Specific T Cell Activation
J.-Y. Chen, S. Agrawal, H.-P. Yi, D. Vallejo, A. Agrawal, A. Lee
Abstract
In this study, efficient T cell activation is demonstrated using cell-sized artificial antigen-presenting cells (aAPCs) with protein-conjugated bilayer lipid membranes that mimic biological cell membranes. The highly uniform aAPCs are generated by a facile method based on standard droplet microfluidic devices. These aAPCs are able to activate the T cells in peripheral blood mononuclear cells (PBMCs), showing a 28-fold increase in IFN{gamma} secretion, a 233-fold increase in antigen-specific CD8 T cells expansion, and a 16-fold increase of CD4 T cell expansion. The aAPCs do not require repetitive boosting or additional stimulants and can function at a relatively low aAPC-to-T cell ratio (1-to-17). The research presents strong evidence that the surface fluidity and size of the aAPCs are critical to the effective formation of immune synapses essential for T cell activation. The findings demonstrate that the microfluidic-generated aAPCs can be instrumental in investigating the physiological conditions and mechanisms for T cell activation. Finally, this method demonstrates the feasibility of customizable aAPCs for a cost-effective off-the-shelf approach to immunotherapy.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synthetic Antigen-Presenting Cells for Adoptive T Cell Therapy
S. N. Dahotre, A. M. Romanov, … G. A. Kwong·bioRxiv·Feb 1, 2021
- Cell surface morphology mimicking nano-bio platform for immune cell stimulation
Beena Varghese, José Alfredo González-Navarro, … Petr Kovaříček·iSciencePeer-reviewed·Sep 25, 2024
- Augmentation of T-cell activation by oscillatory forces and engineered antigen-presenting cells
F. S. Majedi, M. M. Hasani-Sadrabadi, … M. Butte·bioRxiv·Mar 24, 2019
- Lipid-polymer hybrid nanoparticles utilize B cells and dendritic cells to elicit distinct antigen-specific CD4+ and CD8+ T cell responses
M. H. Zhang, B. L. Scotland, … G. L. Szeto·bioRxiv·Jan 23, 2022
- Immunofilaments Provide a Nanoscale Platform for In Vivo T Cell Expansion and Cancer Immunotherapy
L. Weiss, J. Weiden, … R. Hammink·bioRxiv·Oct 14, 2022
- Characterization of CAR T Cells Manufactured using Genetically Engineered Artificial Antigen Presenting Cells
A. Sayadmanesh, M. Azadbakht, … M. Basiri·bioRxiv·Jun 28, 2023